Understanding the Critical Role of Lupus Clinical Trial Outcome Measures in Advancing Therapeutic Development
Join Dr. Anna Wolska from the Lupus Foundation of America and Dr. Laurent Arnaud, Professor of Rheumatology at the Department of Rheumatology, University Hospitals of Strasbourg as they discuss systemic lupus erythematosus (SLE) clinical trials. In this episode, Dr. Arnaud highlights the complexities of drug approval processes in lupus, the pivotal role of large-scale phase three randomized trials and critical outcome measures in these trials, from primary endpoints assessing treatment efficacy to secondary and exploratory measures capturing broader impacts on patient health and quality of life.
Read the article: https://lupus.bmj.com/content/11/1/e001114
Lupus Science and Medicine Podcast
The Lupus Science & Medicine® podcast is your premier source for the latest insights and developments in lupus and related diseases. Each episode features in-depth interviews with authors and leading experts, covering the newest advances in lupus research and treatments.
Lupus Science & Medicine® - lupus.bmj.com - is an esteemed international journal from the BMJ Group and the Lupus Foundation of America (LFA). The journal publishes basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases.
Subscribe now or listen on your favourite podcast platform to enhance your understanding of lupus.
Podcast hosted by:
Dr. Anna Wolska, The Lupus Foundation of America, USA
- No. of episodes: 58
- Latest episode: 2025-05-07
- Health & Fitness Medicine
Where can you listen?
